EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Differences in Parkinson's Disease Populations: Teaching Hospitals Versus Other Settings and Implications for Clinical Trials

Priti Gros iD, Connie Marras, Xuesong Wang, Maria Chiu, Michael E Farkouh, Abby Emdin, Susan E Bronskill

Movement Disorders · 2025

DOI: 10.1002/mds.30239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Priti Gros und 6 weiteren Autor:innen. Beteiligte Einrichtung: Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Heal…. Hauptthemen laut MEDLINE: Parkinson Disease, Hospitals, Teaching, Clinical Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Parkinson Canada, CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson disease (PD) disease‐modifying therapy (DMT) trials generally recruit individuals from teaching hospitals. Whether these participants represent the broader PD population is unclear.

Objective

The objective was to compare individuals with PD seen by neurologists in teaching hospitals early in their disease—a proxy for DMT trial‐eligible cohorts—with individuals seen in other settings.

Methods

This retrospective cohort study using population‐based data from Ontario (Canada) included individuals with PD from 1995 to 2017. Individuals with ≥1 PD visit with a teaching hospital neurologist within 3 years served as a proxy for DMT trial‐eligible participants. Comparators were individuals with PD seen in other settings. We compared age, sex, income, rurality, marginalization, and comorbidities. We measured time to milestones, including drug escalation, surgical/infusion therapies, home care, dementia, long‐term care admission, and death.

Results

We identified 19,948 individuals with PD, of whom 4386 (22.0%) were seen by a teaching hospital neurologist and 15,562 (78.0%) in other settings. Compared to other settings, individuals with teaching hospital neurology visits were younger, belonged to socioeconomically advantaged neighborhoods, and had fewer comorbidities. They had more drug escalation (unadjusted hazard ratio = 1.30; 95% confidence interval [CI] = (1.21, 1.38), surgical or infusion therapies (2.35 [2.09, 2.64]), and home care (1.06 [1.02, 1.10]). They had less dementia (0.813 [0.77, 0.86]), long‐term care admission (0.62 [0.58, 0.67]), and death (0.68 [0.64, 0.72]).

Conclusions

Individuals with PD seen early by teaching hospital neurologists exhibited differences from the PD population. DMT trials in PD may exclude individuals with faster PD progression and from marginalized groups, impacting generalizability. Our study highlights health equity issues. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHospitals, TeachingClinical Trials as TopicHumansMaleFemaleAgedRetrospective StudiesOntarioMiddle AgedAged, 80 and overNeurologistsCohort Studies

Stichwörter der Autor:innen

Parkinson's diseaseclinical trialsdisease progressionhealth administrative dataneurologysocial determinants of health

Autor:innen und Institutionen

  • Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network Toronto, Toronto, Ontario, Canada.
  • Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • ICES, Toronto, Ontario, Canada.
  • Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.
  • Academic Affairs, Cedars-Sinai Health System, Los Angeles, California, USA.

ORCID-Profile: Priti Gros

Förderung

  • Parkinson Canada
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Gros, P., Marras, C., Wang, X., Chiu, M., Farkouh, M. E., Emdin, A., & Bronskill, S. E. (2025). Differences in Parkinson's Disease Populations: Teaching Hospitals Versus Other Settings and Implications for Clinical Trials. Movement Disorders. https://doi.org/10.1002/mds.30239

Vancouver

Gros P, Marras C, Wang X, Chiu M, Farkouh ME, Emdin A, et al. Differences in Parkinson's Disease Populations: Teaching Hospitals Versus Other Settings and Implications for Clinical Trials. Movement Disorders. 2025. doi:10.1002/mds.30239

BibTeX
@article{Gros2025,
  author = {Gros, Priti and Marras, Connie and Wang, Xuesong and Chiu, Maria and Farkouh, Michael E and Emdin, Abby and Bronskill, Susan E},
  title = {Differences in Parkinson's Disease Populations: Teaching Hospitals Versus Other Settings and Implications for Clinical Trials},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30239}
}
Kostenlos starten →